Gastroenterology & Digestive Health
Advancing Celiac Disease Clinical Research
Celiac disease is a chronic autoimmune disorder triggered by gluten consumption, affecting millions worldwide. CenExel partners with sponsors to advance innovative therapies and improve outcomes for pediatric, adolescent, adult, and senior patient populations living with celiac disease and related gastrointestinal conditions.
Studies Conducted
0
+
Trial Participants
0
+
Active Sites
0
+
Overview
Specialized Research for Celiac Disease
CenExel provides advanced clinical research capabilities for celiac disease studies through experienced investigators, dedicated GI research teams, and access to diverse patient populations. Our operational excellence supports efficient enrollment, biomarker analysis, and high-quality data collection from first-patient-in through study completion.
Conditions Covered
Gastrointestinal Conditions We Research
Our gastrointestinal research programs support a broad range of digestive and autoimmune disorders related to celiac disease and gut health.
- Celiac Disease
- Non-Celiac Gluten Sensitivity
- Irritable Bowel Syndrome (IBS)
- Crohn’s Disease
- Ulcerative Colitis
- Gastroesophageal Reflux Disease (GERD)
- Eosinophilic Esophagitis (EoE)
- Microscopic Colitis
Our Approach
Why Sponsors Choose CenExel for Celiac Disease Research
CenExel combines experienced GI investigators, centralized support services, and strong patient recruitment strategies to deliver reliable clinical trial outcomes.
01
Expert GI Research Teams
Our investigators specialize in gastrointestinal and autoimmune disorders with extensive clinical trial experience.
02
Advanced Biomarker Strategies
We support biomarker-driven studies and precision medicine approaches for digestive disease therapies.
03
Diverse Patient Recruitment
Our nationwide network provides access to diverse patient populations across multiple research sites.
04
Efficient Study Execution
CenExel streamlines enrollment, monitoring, and data collection to help sponsors meet study goals faster.
Phase Coverage
Supported Gastrointestinal Trial Phases
CenExel supports early and late-phase gastrointestinal clinical research studies from first-in-human through Phase IV post-market programs.
Active across all phases
- Phase I
- Phase II
- Phase III
- Phase IV
Our GI research programs support sponsor needs with experienced investigators, centralized operations, and scalable recruitment strategies across multiple locations.
Gastroenterology Task Force
CenExel supports a wide range of gastrointestinal and autoimmune clinical trials, delivering scientific expertise, operational excellence, and access to diverse patient populations.
Active Sites
18 Sites
CenExel Phoenix
CenExel Anaheim
CenExel Atlanta
CenExel Marlton
CenExel Gaithersburg
